Insights into the role of a cardiomyopathy-causing genetic variant in ACTN2

Pathogenic variants in ACTN2, coding for alpha-actinin 2, are known to be rare causes of Hyper-trophic Cardiomyopathy. However, little is known about the underlying disease mechanisms. Adult heterozygous mice carrying the Actn2 p.Met228Thr variant were phenotyped by echocar-diography. For homozygous...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Broadway-Stringer, S, Jiang, H, Wadmore, K, Hooper, C, Douglas, G, Steeples, V, Azad, A, Singer, E, Rayet, J, Galatik, F, Ehler, E, Bennett, P, Kalisch-Smith, J, Sparrow, D, Davies, B, Djinovic-Carugo, K, Gautel, M, Watkins, H, Gehmlich, K
Materialtyp: Journal article
Språk:English
Publicerad: MDPI 2023
_version_ 1826311655845265408
author Broadway-Stringer, S
Jiang, H
Wadmore, K
Hooper, C
Douglas, G
Steeples, V
Azad, A
Singer, E
Rayet, J
Galatik, F
Ehler, E
Bennett, P
Kalisch-Smith, J
Sparrow, D
Davies, B
Djinovic-Carugo, K
Gautel, M
Watkins, H
Gehmlich, K
author_facet Broadway-Stringer, S
Jiang, H
Wadmore, K
Hooper, C
Douglas, G
Steeples, V
Azad, A
Singer, E
Rayet, J
Galatik, F
Ehler, E
Bennett, P
Kalisch-Smith, J
Sparrow, D
Davies, B
Djinovic-Carugo, K
Gautel, M
Watkins, H
Gehmlich, K
author_sort Broadway-Stringer, S
collection OXFORD
description Pathogenic variants in ACTN2, coding for alpha-actinin 2, are known to be rare causes of Hyper-trophic Cardiomyopathy. However, little is known about the underlying disease mechanisms. Adult heterozygous mice carrying the Actn2 p.Met228Thr variant were phenotyped by echocar-diography. For homozygous mice, viable E15.5 embryonic hearts were analysed by High Reso-lution Episcopic Microscopy and wholemount staining, complemented by unbiased proteomics, qPCR and Western blotting. Heterozygous Actn2 p.Met228Thr mice have no overt phenotype. Only mature males show molecular parameters indicative of cardiomyopathy. By contrast, the variant is embryonically lethal in the homozygous setting and E15.5 hearts show multiple morphological abnormalities. Molecular analyses, including unbiased proteomics, identified quantitative abnormalities in sarcomeric parameters, cell cycle defects and mitochondrial dys-function. The mutant alpha-actinin protein is found to be destabilised, associated with increased activity of the ubiquitin-proteosomal system. This missense variant in alpha-actinin renders the protein less stable. In response, the ubiquitin-proteosomal system is activated; a mechanism which has been implicated in cardiomyopathies previously. In parallel, lack of functional al-pha-actinin is thought to cause energetic defects through mitochondrial dysfunction. This seems, together with cell cycle defects, the likely cause of death of the embryos. The defects also have wide-ranging morphological consequences.
first_indexed 2024-03-07T08:12:59Z
format Journal article
id oxford-uuid:ab2f9b01-bda2-4b41-b85d-a5d2b0d7fc0a
institution University of Oxford
language English
last_indexed 2024-03-07T08:12:59Z
publishDate 2023
publisher MDPI
record_format dspace
spelling oxford-uuid:ab2f9b01-bda2-4b41-b85d-a5d2b0d7fc0a2023-12-11T09:40:08ZInsights into the role of a cardiomyopathy-causing genetic variant in ACTN2Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ab2f9b01-bda2-4b41-b85d-a5d2b0d7fc0aEnglishSymplectic ElementsMDPI2023Broadway-Stringer, SJiang, HWadmore, KHooper, CDouglas, GSteeples, VAzad, ASinger, ERayet, JGalatik, FEhler, EBennett, PKalisch-Smith, JSparrow, DDavies, BDjinovic-Carugo, KGautel, MWatkins, HGehmlich, KPathogenic variants in ACTN2, coding for alpha-actinin 2, are known to be rare causes of Hyper-trophic Cardiomyopathy. However, little is known about the underlying disease mechanisms. Adult heterozygous mice carrying the Actn2 p.Met228Thr variant were phenotyped by echocar-diography. For homozygous mice, viable E15.5 embryonic hearts were analysed by High Reso-lution Episcopic Microscopy and wholemount staining, complemented by unbiased proteomics, qPCR and Western blotting. Heterozygous Actn2 p.Met228Thr mice have no overt phenotype. Only mature males show molecular parameters indicative of cardiomyopathy. By contrast, the variant is embryonically lethal in the homozygous setting and E15.5 hearts show multiple morphological abnormalities. Molecular analyses, including unbiased proteomics, identified quantitative abnormalities in sarcomeric parameters, cell cycle defects and mitochondrial dys-function. The mutant alpha-actinin protein is found to be destabilised, associated with increased activity of the ubiquitin-proteosomal system. This missense variant in alpha-actinin renders the protein less stable. In response, the ubiquitin-proteosomal system is activated; a mechanism which has been implicated in cardiomyopathies previously. In parallel, lack of functional al-pha-actinin is thought to cause energetic defects through mitochondrial dysfunction. This seems, together with cell cycle defects, the likely cause of death of the embryos. The defects also have wide-ranging morphological consequences.
spellingShingle Broadway-Stringer, S
Jiang, H
Wadmore, K
Hooper, C
Douglas, G
Steeples, V
Azad, A
Singer, E
Rayet, J
Galatik, F
Ehler, E
Bennett, P
Kalisch-Smith, J
Sparrow, D
Davies, B
Djinovic-Carugo, K
Gautel, M
Watkins, H
Gehmlich, K
Insights into the role of a cardiomyopathy-causing genetic variant in ACTN2
title Insights into the role of a cardiomyopathy-causing genetic variant in ACTN2
title_full Insights into the role of a cardiomyopathy-causing genetic variant in ACTN2
title_fullStr Insights into the role of a cardiomyopathy-causing genetic variant in ACTN2
title_full_unstemmed Insights into the role of a cardiomyopathy-causing genetic variant in ACTN2
title_short Insights into the role of a cardiomyopathy-causing genetic variant in ACTN2
title_sort insights into the role of a cardiomyopathy causing genetic variant in actn2
work_keys_str_mv AT broadwaystringers insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT jiangh insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT wadmorek insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT hooperc insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT douglasg insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT steeplesv insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT azada insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT singere insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT rayetj insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT galatikf insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT ehlere insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT bennettp insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT kalischsmithj insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT sparrowd insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT daviesb insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT djinoviccarugok insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT gautelm insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT watkinsh insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2
AT gehmlichk insightsintotheroleofacardiomyopathycausinggeneticvariantinactn2